UBS Reiterates Neutral Rating on Myriad Genetics (MYGN)
Go back to UBS Reiterates Neutral Rating on Myriad Genetics (MYGN)| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.17 +0.15 (4.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.02 | 52 Week High | $45.34 | |||
| Open | $3.00 | 52 Week Low | $15.92 | |||
| Day High | $3.23 | P/E | 1.36 | |||
| Day Low | $3.00 | EPS | $2.33 | |||
| Volume | 3,499,796 | |||||
